New drug discovery technique using skin cells reveals promising new drugs
Out of 2,000 compounds, the screen found a family of new drugs, including an existing drug called UDCA, that allowed the mitochondria to work again.
Out of 2,000 compounds, the screen found a family of new drugs, including an existing drug called UDCA, that allowed the mitochondria to work again.
With protein phosphorylation, scientists are reminded that being at the scene of a crime does not necessarily mean being involved in the crime.
Drugs called PARP inhibitors are currently undergoing clinical trials for a number of cancers. Will they be helpful in Parkinson’s disease as well?
Deep brain simulation for late-stage, early onset Parkinson’s might provide some hope for those for whom medications no longer work well.
Glucose control may be one way to slow the degenerative process in Parkinson’s. Once again we see an association of blood glucose, diabetes and neurodegenerative diseases. Description: “1Sobell Department of Motor Neuroscience, UCL Institute of Neurology, London, United Kingdom. 2Department of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom. 3Reta Lila Weston […]
A genetic mutation that is responsible for a small minority of Parkinson’s cases points to the contribution of chronic neuroinflammation and oxidative stress that probably underlies all “sporadic” cases of Parkinson’s disease. Description: “News Release“ Source Link: http://www.scripps.edu/news/press/2013/20130724reed.html posted on my Facebook page: Parkinson’s News
A patent was issued for a “transcranial direct current stimulation” system to reduce symptoms of Parkinson’s disease. Curious what are the side effects compared to the current medications? Of course we are still only talking about supportive therapy, rather than any kind of treatment. Would you use it? Description: “VALLEY VIEW, Ohio — Great Lakes […]